Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Gholamhoseinian Najar

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advanced Biomedical Research|March 7, 2014
Effect of urotensin II on apolipoprotein B100 and apolipoprotein A-I expression in HepG2 cell lineAbbas Mohammadi, Ahmad Gholamhoseinian Najar, Amirhosein Khoshi
Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2012
c-Src antisense complexed with PAMAM denderimes decreases of c-Src expression and EGFR-dependent downstream genes in the human HT-29 colon cancer cell lineAli Reza Nourazarian, Roghiyeh Pashaei-Asl, Yadollah Omidi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 29, 2013
EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell lineAhmad Gholamhoseinian Najar, Roghiyeh Pashaei-Asl, Yadollah Omidi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 22, 2012
Combined EGFR and c-Src antisense oligodeoxynucleotides encapsulated with PAMAM Denderimers inhibit HT-29 colon cancer cell proliferationAli Reza Nourazarian, Ahmad Gholamhoseinian Najar, Safar Farajnia, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advanced Biomedical Research|March 7, 2014
Effect of urotensin II on apolipoprotein B100 and apolipoprotein A-I expression in HepG2 cell lineAbbas Mohammadi, Ahmad Gholamhoseinian Najar, Amirhosein Khoshi
Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2012
c-Src antisense complexed with PAMAM denderimes decreases of c-Src expression and EGFR-dependent downstream genes in the human HT-29 colon cancer cell lineAli Reza Nourazarian, Roghiyeh Pashaei-Asl, Yadollah Omidi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 29, 2013
EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell lineAhmad Gholamhoseinian Najar, Roghiyeh Pashaei-Asl, Yadollah Omidi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 22, 2012
Combined EGFR and c-Src antisense oligodeoxynucleotides encapsulated with PAMAM Denderimers inhibit HT-29 colon cancer cell proliferationAli Reza Nourazarian, Ahmad Gholamhoseinian Najar, Safar Farajnia, et al.
Pageof 1